We are live on ! Find out more
BC

Bruce & Co Portfolio holdings

AUM $350M
1-Year Est. Return 33.5%
This Fund
S&P 500
This Quarter Est. Return
-0.42%
1 Year Est. Return
+33.5%
3 Year Est. Return
+65.72%
5 Year Est. Return
+73.85%
10 Year Est. Return
+249.08%
AUM
$489M
AUM Growth
-$11.1M
Cap. Flow
-$21.4M
Cap. Flow %
-4.37%
Top 10 Hldgs %
70.61%
Holding
33
New
1
Increased
1
Reduced
9
Closed
1

Top Buys

Rank Stock Value
1
T icon
AT&T
T
+$22.6M
2
PRTK
Paratek Pharmaceuticals, Inc.
PRTK
+$429K

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$8.72M
2
SUPN icon
Supernus Pharmaceuticals
SUPN
+$5.52M
3
AAPL icon
Apple
AAPL
+$5.04M
4
ALL icon
Allstate
ALL
+$2.51M
5
ABT icon
Abbott
ABT
+$1.24M

Sector Composition

Rank Sector Weight
1 Healthcare 34.95%
2 Utilities 29.7%
3 Industrials 11.15%
4 Financials 7.96%
5 Communication Services 5.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UHAL icon
1
U-Haul Holding Co
UHAL
$13.9B
$45M 9.2%
753,550
NEE icon
2
NextEra Energy
NEE
$185B
$41.5M 8.49%
490,000
-400
-0.1% -$32.1K
ABBV icon
3
AbbVie
ABBV
$450B
$39.5M 8.07%
243,500
-60,000
-20% -$8.72M
ALL icon
4
Allstate
ALL
$64.3B
$38.7M 7.91%
279,300
-20,000
-7% -$2.51M
CMS icon
5
CMS Energy
CMS
$22.8B
$32.8M 6.7%
468,500
DUK icon
6
Duke Energy
DUK
$97.5B
$32M 6.53%
286,200
BHC icon
7
Bausch Health
BHC
$1.8B
$31.6M 6.45%
1,381,000
XEL icon
8
Xcel Energy
XEL
$49.2B
$29.8M 6.09%
412,500
PFE icon
9
Pfizer
PFE
$143B
$28.1M 5.74%
542,700
-1,000
-0.2% -$51.9K
MRK icon
10
Merck
MRK
$315B
$26.6M 5.43%
323,700
AAPL icon
11
Apple
AAPL
$4.9T
$24M 4.91%
137,400
-30,000
-18% -$5.04M
T icon
12
AT&T
T
$152B
$21.8M 4.45%
+1,220,728
New +$22.6M
ABT icon
13
Abbott
ABT
$175B
$19.8M 4.06%
167,600
-10,000
-6% -$1.24M
GE icon
14
GE Aerospace
GE
$364B
$9.55M 1.95%
167,532
AVA icon
15
Avista
AVA
$3.45B
$9.26M 1.89%
205,000
SUPN icon
16
Supernus Pharmaceuticals
SUPN
$2.79B
$7.18M 1.47%
222,105
-180,000
-45% -$5.52M
NEM icon
17
Newmont
NEM
$95.8B
$5.16M 1.06%
65,000
SIRI icon
18
SiriusXM
SIRI
$10.3B
$5.02M 1.03%
75,784
-10,000
-12% -$629K
PRTK
19
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$4.63M 0.95%
1,557,312
+114,000
+8% +$429K
FOCL
20
EDAP TMS S.A.
FOCL
$204M
$4.1M 0.84%
565,652
AMYT
21
DELISTED
Amryt Pharma plc American Depositary Shares
AMYT
$2.6M 0.53%
315,182
ASH icon
22
Ashland
ASH
$3.14B
$2.46M 0.5%
25,000
FATE icon
23
Fate Therapeutics
FATE
$324M
$2.21M 0.45%
57,000
IGMS
24
DELISTED
IGM Biosciences
IGMS
$1.47M 0.3%
55,000
MNKD icon
25
MannKind Corp
MNKD
$1.25B
$1.45M 0.3%
395,073

Similar funds

Bruce & Co's Q1 2022 Portfolio in Review

As of Q1 2022, Bruce & Co held 33 positions worth $489M, down 2.2% from $500M the previous quarter. Its ten largest holdings account for 71% of the portfolio.

Bruce & Co withdrew a net $21.4M in Q1 2022, closing 1 position and reducing 9 holdings. Its most notable exit was Flotek Industries, an estimated $476K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, down from 39% a quarter earlier, followed by Utilities and Industrials.

Against the trend, Bruce & Co opened a new position in AT&T worth $21.8M.

  • Bruce & Co's largest Q1 2022 buy was AT&T: 1,220,728 shares worth $21.8M.
  • Bruce & Co added most to Paratek Pharmaceuticals, Inc. in Q1 2022, an estimated $429K increase.
  • Bruce & Co's biggest Q1 2022 reduction was AbbVie, cutting an estimated $8.72M.
  • Bruce & Co fully exited Flotek Industries in Q1 2022, selling an estimated $476K.
  • Bruce & Co's ten largest holdings make up 71% of its $489M portfolio in Q1 2022.
  • Bruce & Co opened 1 new position and closed 1 in Q1 2022.
  • Bruce & Co's portfolio value fell 2.2% quarter-over-quarter to $489M.

Based on Bruce & Co's 13F filing for Q1 2022, filed 11 May 2022.